Yuanta Securities discusses what will be South Korea’s leading stocks
Daniel Yoo, head of global asset allocation at Yuanta Securities, says “the [artificial intelligence] cycle is here to stay for at least … another two years.”
Similar Posts
AMD’s AI narrative overshadowed last years’ misses, says Bernstein’s Stacy Rasgon
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Fast Money Stacy Rasgon, Bernstein, joins ‘Fast Money’ to talk the recent tech run and its impact on the AI and semiconductor sector. 04:01 13 minutes ago
Europe firms can compete with U.S. and China peers in AI: Mistral AI
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Florian Bressand, chief business officer of Mistral AI, says “we really see this as a lively ecosystem where no company, given the importance of this technology, will want to rely on a single provider.”
Google cuts hit Moonshots Factory
CNBC’s Deirdre Bosa reports on news from layoffs at Google.
Versuni CEO explains its decision to open its second factory in India
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Henk S. De Jong, CEO of Versuni, says it’s important to make its products locally “because then you can react fast to everything that’s happening in the Indian market.”
Revisiting Maui six months after devastating wildfires
Hosted by Brian Sullivan, “Last Call” is a fast-paced, entertaining business show that explores the intersection of money, culture and policy. Tune in Monday through Friday at 7 p.m. ET on CNBC.
Drug name…or Star Wars planet?
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Prescription drugs have weird names. But so do planets in the Star Wars universe. We asked CNBC staffers whether they could tell the difference. 02:04 Fri, Apr 10 20159:30 AM EDT